CURE Pharmaceutical announces CUREform drug delivery line
CURE Pharmaceutical announces the expansion of its oral drug delivery product line creating CUREform which includes CUREfilm, an oral thin film. The new line adds CUREpods chewables and emulsions to meet increased demand for alternative dosage forms. CUREform solutions seek to increase drug bioavailability, protect from degradation and offer better palatability through taste masking. The company's technology includes the new CUREpods, which is a novel chewable delivery system, as well as nano and microemulsions that can be incorporated into various finished dosage forms, including CUREfilm. To meet the increased market demand, CURE will be expanding its manufacturing footprint by 50%, adding new blending, casting and packaging equipment to handle new drug delivery forms at scale. CURE is equipped with a cGMP 25,000 square feet production plant in Oxnard, CA for its manufacturing.